Gurugram (Haryana)-based manufacturer and marketer of Active Pharmaceutical Ingredients (bulk drugs) across anticoagulant, anti-diabetic, antihypertensive, antibiotic and other therapeutic segments.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 14 | 10 | 1 | -4 | -1 | 5 | 7 | 13 |
| Borrowings | 45 | 41 | 53 | 44 | 39 | 33 | 36 | 35 |
| Other Liabilities | 43 | 54 | 63 | 56 | 57 | 68 | 54 | 51 |
| Total Liabilities | 107 | 109 | 121 | 100 | 99 | 111 | 101 | 103 |
| AssetsFixed Assets | 28 | 35 | 34 | 32 | 31 | 33 | 34 | 37 |
| CWIP | 6 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 72 | 74 | 87 | 68 | 68 | 78 | 68 | 66 |
| Total Assets | 107 | 109 | 121 | 100 | 99 | 111 | 101 | 103 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | -3 | 0 | 6 | 8 | -7 | 15 | 21 | 11 |
| Cash from Investing | -2 | -9 | -14 | -1 | -3 | -1 | -5 | -8 |
| Cash from Financing | 4 | 8 | 8 | -8 | 10 | -13 | -17 | -3 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -5 | -9 | -8 | 6 | -10 | 13 | 17 | 3 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
530313 · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.